Tests myoelectric biofeedback to help arm movement after stroke
Tests myoelectric biofeedback with rehabilitation training in older adults with stroke-related arm weakness.
Plain-language title generated from the registry record
Registry title: Effects of Myoelectric Biofeedback on Upper Limb Function in Post-stroke Patients
Key facts
- Where
- Yiwu, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 65 and 80 years old?
Source: NCT06443008, who can take part
Where in China
- Yinkai ChengYiwu, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Trial code
- NCT06443008
- Record updated
- 17 February 2025
- Original description
The purpose of this clinical trial is to investigate the effect of myoelectric biofeedback therapy on upper limb function in elderly patients with cerebral infarction, and to analyze the adjustment of stroke condition and quality of life.The main questions it aims to answer are:Read full original descriptionShow less
Objective To Investigate the Effect of Myoelectric Biofeedback Therapy Combined With Comprehensive Rehabilitation Training on Upper Extremity Motor Function in Elderly Patients With Hemiplegia With Cerebral Infarction
The purpose of this clinical trial is to investigate the effect of myoelectric biofeedback therapy on upper limb function in elderly patients with cerebral infarction, and to analyze the adjustment of stroke condition and quality of life.The main questions it aims to answer are:
1. Does myoelectric biofeedback therapy promote the restoration of upper limb function in elderly patients with cerebral infarction? 2. What medical problems do participants have with myoelectric biofeedback therapy?
Inclusion: Subject volunteered to participate in the experiment and signed informed consent; Age ≥ 65 years old, no gender limit; Diagnosis of stroke patients; No other major cardiovascular diseases.
Exclusion: Subjects with skin allergies; People with severe consciousness disorders, severe dementia, speech disorders, etc. who are unable to communicate and describe the disease; Subject's poor compliance; Those who do not meet the criteria for diagnosis and inclusion; can not cooperate as required, poor compliance; participants in other clinical trials.